The Food and Drug Administration (FDA) has once again expanded their recall of the high blood pressure medication Valsartan due to concerns that it could contain a cancer-causing ingredient.
According to the FDA, Valsartan is a drug that is commonly used to treat high blood pressure and congestive heart failure. The medication was first recalled on July 13 after tests suggested that it could contain a cancer-causing substance known as N-Nitrosodimethylamine (NDMA).
Research by the Environmental Protection Agency (EPA) shows that NDMA was previously used in the production of rocket fuel, as well as antioxidants and softeners for copolymers. It is now only used for research purposes.
Valsartan tablets distributed by the following pharmaceuticals are included in the recall:
Several other medications containing Valsartan have also been recalled. A full list can be found here.
Any adverse reactions to the drug should be reported to the FDA, and consumers taking Valsartan tablets are urged to immediately contact their doctors for a prescription change. Contact Qualanex, LLC at 1-800-505-9291 with any further questions or concerns.
Thomas J. Henry Injury Attorneys are leaders in the area of drug and product liability litigation. Our Defective Drug and Products Division have extensive knowledge and resources in order to represent our clients efficiently and aggressively. The Defective Drug and Products Division represent a multitude of people who are battling against manufacturers of medical devices and/or defective pharmaceuticals.
If you or a loved one have been injured by or have developed serious side-effects from the use of recalled medications or pharmaceuticals, contact Thomas J. Henry immediately. We represent clients/victims all over the country. We are available 24/7, nights and weekends.